Efficacy and Safety of Anti–Programmed Death-Ligand 1 Monoclonal Antibody Socazolimab With Carboplatin and Etoposide for Extensive-Stage SCLC: Results From the Phase 1b Clinical Trial
- Resource Type
- Article
- Source
- In
JTO Clinical and Research Reports April 2023 4(4) - Subject
- Language
- ISSN
- 2666-3643